文献速递运动医学关节外科

富集骨髓穿刺液生物增强在关节镜下肩袖修复术患者中的前瞻性随机试验

Prospective Randomized Trial of Biologic Augmentation With Bone Marrow Aspirate Concentrate in Patients Undergoing Arthroscopic Rotator Cuff Repair.
PubMed 文献 · Am J Sports Med · 2023-02-22

该随机对照试验将孤立性1至3厘米冈上肌腱撕裂患者随机分为cBMA增强组与假切口组,比较关节镜下肩袖修复术后临床功能与肩袖结构完整性。cBMA组1年MRI的Sugaya分类再撕裂证据显著少于对照组,但两组治疗失败率及患者报告临床结局无显著差异。

要点

  • cBMA增强组1年MRI的Sugaya分类再撕裂证据显著少于对照组(18% vs 57%,P<.001)。
  • 两组功能评分自6个月起均显著改善并维持至2年(均P<.05)。
  • 两组治疗失败率无显著差异(cBMA组15% vs 对照组16%)。

核心结论

  • cBMA增强的关节镜下肩袖修复术可能带来结构上更优的修复,但在治疗失败率和患者报告临床结局方面与单纯关节镜下肩袖修复术相比基本未能显著改善。
  • 作者认为需要进一步研究以探讨改善修复质量对临床结局和修复失败率的长期益处。

研究设计与样本

  • 随机对照试验,证据等级1级。
  • 纳入孤立性1至3厘米冈上肌腱撕裂并拟行关节镜下肩袖修复术的患者,随机接受辅助性cBMA注射或假切口。
  • 从髂嵴抽取骨髓,使用市售系统浓缩,修复后在关节镜下肩袖修复部位注射。
  • 共纳入91例患者(对照组n=45,cBMA组n=46);82例(90%)完成2年临床随访,75例(82%)完成1年MRI。
  • 术前及术后连续评估至2年,功能指标包括ASES、SANE、Simple Shoulder Test、12项简表健康调查和Veterans RAND 12项健康调查;术后1年行MRI按Sugaya分类评估肩袖结构完整性。

主要发现

  • 两组功能指标在6个月时均显著改善,并在1年和2年时维持(均P<.05)。
  • 对照组1年MRI按Sugaya分类的肩袖再撕裂证据显著多于cBMA组(57% vs 18%;P<.001)。
  • 治疗失败在每组各7例患者中发生(对照组16%;cBMA组15%)。

关键数值与推荐

  • 治疗失败定义为:与术前基线相比1年或2年ASES或SANE评分下降、需要翻修肩袖修复术、或转为全肩关节置换术。
  • 再撕裂评估采用Sugaya分类。

局限性

  • 作者认为需要进一步研究以探讨改善修复质量对临床结局和修复失败率的长期益处。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although initial studies have demonstrated that concentrated bone marrow aspirate (cBMA) injections promote rotator cuff repair (RCR) healing, there are no randomized prospective studies investigating clinical efficacy. HYPOTHESIS/PURPOSE: To compare outcomes after arthroscopic RCR (aRCR) with and without cBMA augmentation. It was hypothesized that cBMA augmentation would result in statistically significant improvements in clinical outcomes and rotator cuff structural integrity. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: Patients indicated for aRCR of isolated 1- to 3-cm supraspinatus tendon tears were randomized to receive adjunctive cBMA injection or sham incision. Bone marrow was aspirated from the iliac crest, concentrated using a commercially available system, and injected at the aRCR site after repair. Patients were assessed preoperatively and serially until 2 years postoperatively via the following functional indices: American Shoulder and Elbow Surgeons (ASES), Single Assessment Numeric Evaluation (SANE), Simple Shoulder Test, 12-Item Short Form Health Survey, and Veterans RAND 12-Item Health Survey. Magnetic resonance imaging (MRI) was performed at 1 year to assess rotator cuff structural integrity according to Sugaya classification. Treatment failure was defined as decreased 1- or 2-year ASES or SANE scores as compared with preoperative baseline, the need for revision RCR, or conversion to total shoulder arthroplasty. RESULTS: An overall 91 patients were enrolled (control, n = 45; cBMA, n = 46): 82 (90%) completed 2-year clinical follow-up and 75 (82%) completed 1-year MRI. Functional indices significantly improved in both groups by 6 months and were sustained at 1 and 2 years (all P < .05). The control group showed significantly greater evidence of rotator cuff retear according to Sugaya classification on 1-year MRI (57% vs 18%; P < .001). Treatment failed for 7 patients in each group (control, 16%; cBMA, 15%). CONCLUSION: cBMA-augmented aRCR of isolated supraspinatus tendon tears may result in a structurally superior repair but largely fails to significantly improve treatment failure rates and patient-reported clinical outcomes when compared with aRCR alone. Additional study is warranted to investigate the long-term benefits of improved repair quality on clinical outcomes and repair failure rates. REGISTRATION: NCT02484950 (ClinicalTrials.gov identifier).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Cole BJ, Kaiser JT, Wagner KR, et al. Prospective Randomized Trial of Biologic Augmentation With Bone Marrow Aspirate Concentrate in Patients Undergoing Arthroscopic Rotator Cuff Repair. Am J Sports Med. 2023. PMID: 36811557. doi:10.1177/03635465231154601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。